Form 8-K DEXCOM INC For: Nov 06

Go back to Form 8-K DEXCOM INC For: Nov 06

DexCom (DXCM) PT Raised to $150 at Oppenheimer

November 7, 2018 9:35 AM EST

Oppenheimer analyst Steven Lichtman raised the price target on DexCom (NASDAQ: DXCM) to $150.00 (from $125.00) while maintaining a Outperform rating.

The analyst commented, "DXCM's 3Q18 sales of $267M (+45% cc) beat our/consensus' $241/$243M, led by strong outperformance in International and better... More